首页 > 最新文献

Internal Medicine最新文献

英文 中文
Superficial Primary Malignant Melanoma of the Esophagus Detected and Treated at Stage 0. 一例食道浅表原发性恶性黑色素瘤在 0 期时被发现并得到治疗。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-15 Epub Date: 2024-03-25 DOI: 10.2169/internalmedicine.2454-23
Yuzo Toyama, Ryuji Nagahama, Yu Kodama, Izumi Kaieda, Shinjiro Sakai, Gen Maeda, Hidemitsu Nishizawa, Shingo Asahara, Yuji Mizokami

The patient was a 79-year-old male. At three years and eight months after his initial presentation, upper gastrointestinal endoscopy revealed a black-flattened elevated lesion in the middle third of the esophagus, which was diagnosed as malignant melanoma on biopsy. No lymph node or distant metastasis was found. A diagnosis of cT1bN0M0 Stage I was thus made. We performed a robot-assisted, minimally invasive esophagectomy and D2 dissection. The postoperative diagnosis was pT1a-MM, N0, M0, vascular invasion+, stage 0. The patient was recurrence-free for 14 months after surgery. We presume that an aggressive biopsy diagnosis is important for the early detection of malignant melanoma.

患者是一名 79 岁的男性。在他初次就诊三年零八个月后,上消化道内窥镜检查发现食管中三分之一处有一个黑色扁平的隆起病灶,活检后诊断为恶性黑色素瘤。未发现淋巴结或远处转移。因此诊断为 cT1bN0M0 I 期。我们在机器人辅助下进行了微创食管切除术和 D2 切除术。术后诊断为pT1a(MM),N0,M0,血管侵犯+,0期。我们认为,积极的活检诊断对于早期发现恶性黑色素瘤非常重要。
{"title":"Superficial Primary Malignant Melanoma of the Esophagus Detected and Treated at Stage 0.","authors":"Yuzo Toyama, Ryuji Nagahama, Yu Kodama, Izumi Kaieda, Shinjiro Sakai, Gen Maeda, Hidemitsu Nishizawa, Shingo Asahara, Yuji Mizokami","doi":"10.2169/internalmedicine.2454-23","DOIUrl":"10.2169/internalmedicine.2454-23","url":null,"abstract":"<p><p>The patient was a 79-year-old male. At three years and eight months after his initial presentation, upper gastrointestinal endoscopy revealed a black-flattened elevated lesion in the middle third of the esophagus, which was diagnosed as malignant melanoma on biopsy. No lymph node or distant metastasis was found. A diagnosis of cT1bN0M0 Stage I was thus made. We performed a robot-assisted, minimally invasive esophagectomy and D2 dissection. The postoperative diagnosis was pT1a-MM, N0, M0, vascular invasion+, stage 0. The patient was recurrence-free for 14 months after surgery. We presume that an aggressive biopsy diagnosis is important for the early detection of malignant melanoma.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":"3049-3053"},"PeriodicalIF":1.0,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11637794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140206806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Factors of Unexpected Hospitalization within Six Months of Undergoing Percutaneous Coronary Intervention in Patients with Chronic Coronary Disease. 慢性冠心病患者接受经皮冠状动脉介入治疗后六个月内意外住院的预测因素。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.3929-24
Tetsuo Furukawa, Isamu Mizote, Tatsuya Shiraki, Daisuke Nakamura, Mayu Nishio, Naoki Fukushima, Takashi Kitao, Kensuke Yokoi, Masahiro Kumada, Motoaki Kitagawa, Kunihiko Nagai, Kiyoshi Kume, Keiji Hirooka, Tsutomu Nakagawa, Tohru Ohama, Mitsuyoshi Takahara, Shungo Hikoso, Yasushi Sakata

Background Recent guidelines recommend dual antiplatelet therapy (DAPT) for six months following percutaneous coronary intervention (PCI) in patients with chronic coronary disease, as unexpected hospitalization can trigger DAPT discontinuation. This study evaluated the predictive factors for unexpected hospitalization within six months after PCI in patients with chronic coronary disease. Methods This prospective multicenter study included 412 patients who underwent PCI for chronic coronary disease. Unexpected hospitalization was defined as a prolonged hospital stay, unscheduled readmission, and all-cause mortality. The predictive factors for unexpected hospitalization within six months post-PCI were evaluated using the Cox regression model. Results The rate of unexpected hospitalization 6 months after PCI was 10.8%±1.5%. Unexpected hospitalizations due to bleeding events accounted for 12.1% (n=5/41), whereas non-bleeding readmissions accounted for 87.9% (n=36/41). A multivariable analysis revealed that the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) major criteria met [adjusted hazard ratio (HR), 1.55; 95% confidence interval (CI), 1.05-2.29; P=0.026], body weight (adjusted HR, 2.44; 95% CI 1.33-4.49; P=0.004), and presence of diabetes mellitus (adjusted HR, 1.94; 95% CI 1.09-3.47; P=0.025) were independent risk factors for unexpected hospitalization. Among the major ARC-HBR criteria, oral anticoagulant use (adjusted HR, 2.39; 95% CI, 1.14-5.02, P=0.021) and active malignancy (adjusted HR, 3.85; 95% CI, 1.47-10.05; P=0.006) were significantly associated with unexpected hospitalization after adjusting for a low body weight and diabetes mellitus. Conclusions The majority of unexpected hospitalizations after PCI in patients with chronic coronary disease are attributed to non-bleeding causes. The assessment using major ARC-HBR criteria in these patients not only addresses bleeding risks but also underscores its predictive value in conjunction with a low body weight and diabetes mellitus for the prediction of unexpected hospitalization.

背景 最近的指南建议慢性冠状动脉疾病患者在经皮冠状动脉介入治疗(PCI)后六个月内使用双重抗血小板疗法(DAPT),因为意外住院可能会导致 DAPT 的终止。本研究评估了慢性冠心病患者 PCI 术后 6 个月内意外住院的预测因素。方法 这项前瞻性多中心研究纳入了 412 名因慢性冠心病接受 PCI 治疗的患者。意外住院定义为住院时间延长、非计划再入院和全因死亡。采用 Cox 回归模型评估了 PCI 术后 6 个月内意外住院的预测因素。结果 PCI术后6个月内意外住院率为10.8%±1.5%。因出血事件导致的意外住院率为12.1%(5/41),而非出血再入院率为87.9%(36/41)。多变量分析显示,符合高出血风险学术研究联盟(ARC-HBR)主要标准的数量[调整后危险比(HR),1.55;95% 置信区间(CI),1.05-2.29;P=0.026]、体重(调整后危险比,2.44;95% 置信区间(CI),1.33-4.49;P=0.004)和是否患有糖尿病(调整后危险比,1.94;95% 置信区间(CI),1.09-3.47;P=0.025)是意外住院的独立危险因素。在 ARC-HBR 的主要标准中,口服抗凝药(调整后 HR,2.39;95% CI,1.14-5.02;P=0.021)和活动性恶性肿瘤(调整后 HR,3.85;95% CI,1.47-10.05;P=0.006)在调整低体重和糖尿病后与意外住院显著相关。结论 慢性冠状动脉疾病患者PCI术后意外住院的大部分原因是非出血。在这些患者中使用主要的 ARC-HBR 标准进行评估,不仅能解决出血风险问题,还能强调其与低体重和糖尿病一起在预测意外住院方面的预测价值。
{"title":"Predictive Factors of Unexpected Hospitalization within Six Months of Undergoing Percutaneous Coronary Intervention in Patients with Chronic Coronary Disease.","authors":"Tetsuo Furukawa, Isamu Mizote, Tatsuya Shiraki, Daisuke Nakamura, Mayu Nishio, Naoki Fukushima, Takashi Kitao, Kensuke Yokoi, Masahiro Kumada, Motoaki Kitagawa, Kunihiko Nagai, Kiyoshi Kume, Keiji Hirooka, Tsutomu Nakagawa, Tohru Ohama, Mitsuyoshi Takahara, Shungo Hikoso, Yasushi Sakata","doi":"10.2169/internalmedicine.3929-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.3929-24","url":null,"abstract":"<p><p>Background Recent guidelines recommend dual antiplatelet therapy (DAPT) for six months following percutaneous coronary intervention (PCI) in patients with chronic coronary disease, as unexpected hospitalization can trigger DAPT discontinuation. This study evaluated the predictive factors for unexpected hospitalization within six months after PCI in patients with chronic coronary disease. Methods This prospective multicenter study included 412 patients who underwent PCI for chronic coronary disease. Unexpected hospitalization was defined as a prolonged hospital stay, unscheduled readmission, and all-cause mortality. The predictive factors for unexpected hospitalization within six months post-PCI were evaluated using the Cox regression model. Results The rate of unexpected hospitalization 6 months after PCI was 10.8%±1.5%. Unexpected hospitalizations due to bleeding events accounted for 12.1% (n=5/41), whereas non-bleeding readmissions accounted for 87.9% (n=36/41). A multivariable analysis revealed that the number of Academic Research Consortium for High Bleeding Risk (ARC-HBR) major criteria met [adjusted hazard ratio (HR), 1.55; 95% confidence interval (CI), 1.05-2.29; P=0.026], body weight (adjusted HR, 2.44; 95% CI 1.33-4.49; P=0.004), and presence of diabetes mellitus (adjusted HR, 1.94; 95% CI 1.09-3.47; P=0.025) were independent risk factors for unexpected hospitalization. Among the major ARC-HBR criteria, oral anticoagulant use (adjusted HR, 2.39; 95% CI, 1.14-5.02, P=0.021) and active malignancy (adjusted HR, 3.85; 95% CI, 1.47-10.05; P=0.006) were significantly associated with unexpected hospitalization after adjusting for a low body weight and diabetes mellitus. Conclusions The majority of unexpected hospitalizations after PCI in patients with chronic coronary disease are attributed to non-bleeding causes. The assessment using major ARC-HBR criteria in these patients not only addresses bleeding risks but also underscores its predictive value in conjunction with a low body weight and diabetes mellitus for the prediction of unexpected hospitalization.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Severe Fever with Thrombocytopenia Syndrome and Acute Gastric Mucosal Lesions Confirmed Using Esophagogastroduodenoscopy. 一例通过食管胃十二指肠镜检查确诊的重度发热伴血小板减少综合征和急性胃黏膜病变病例
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4416-24
Koki Kitagawa, Mitsuhiro Kitani, Tetsuro Saito, Naoto Yoshitake, Shogo Shirota

Severe fever with thrombocytopenia syndrome (SFTS) is known to cause gastrointestinal hemorrhaging; however, few reports have so far specified the site of the hemorrhaging or lesion characteristics. A 79-year-old man was admitted to the hospital with fever, anorexia, and diarrhea which was suspected to be due to gastroenteritis. On day 2, the patient developed hematemesis. Esophagogastroduodenoscopy revealed an acute gastric mucosal lesion. Further physical examination revealed an eschar, and the blood test was positive for SFTS virus nucleic acid. This case suggests that SFTS-associated gastrointestinal hemorrhage may be caused by acute gastritis. SFTS should therefore be considered in cases with fever, gastrointestinal symptoms, and thrombocytopenia.

众所周知,严重发热伴血小板减少综合征(SFTS)可导致胃肠道出血,但迄今为止,很少有报告明确指出出血部位或病变特征。一名 79 岁的男性因发热、厌食和腹泻入院,怀疑是肠胃炎所致。第 2 天,患者出现吐血。食管胃十二指肠镜检查发现急性胃粘膜病变。进一步的体格检查发现了焦痂,血液检测显示 SFTS 病毒核酸呈阳性。该病例表明,SFTS 相关性消化道出血可能是由急性胃炎引起的。因此,有发热、胃肠道症状和血小板减少的病例应考虑SFTS。
{"title":"A Case of Severe Fever with Thrombocytopenia Syndrome and Acute Gastric Mucosal Lesions Confirmed Using Esophagogastroduodenoscopy.","authors":"Koki Kitagawa, Mitsuhiro Kitani, Tetsuro Saito, Naoto Yoshitake, Shogo Shirota","doi":"10.2169/internalmedicine.4416-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4416-24","url":null,"abstract":"<p><p>Severe fever with thrombocytopenia syndrome (SFTS) is known to cause gastrointestinal hemorrhaging; however, few reports have so far specified the site of the hemorrhaging or lesion characteristics. A 79-year-old man was admitted to the hospital with fever, anorexia, and diarrhea which was suspected to be due to gastroenteritis. On day 2, the patient developed hematemesis. Esophagogastroduodenoscopy revealed an acute gastric mucosal lesion. Further physical examination revealed an eschar, and the blood test was positive for SFTS virus nucleic acid. This case suggests that SFTS-associated gastrointestinal hemorrhage may be caused by acute gastritis. SFTS should therefore be considered in cases with fever, gastrointestinal symptoms, and thrombocytopenia.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination: A Case Report. 接种 mRNA 冠状病毒疾病 2019 疫苗后出现急性严重结肠炎:病例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4224-24
Akira Nakanishi, Sakuma Takahashi, Tomoki Inaba, Eriko Yasutomi, Hugh Shunsuke Colvin, Koichi Izumikawa, Shigenao Ishikawa, Masaki Wato, Midori Ando, Satoko Nakamura

A 74-year-old woman developed acute severe colitis after receiving her sixth mRNA vaccine against coronavirus disease-2019 (COVID-19). On the day after vaccination, she experienced bloody diarrhea, abdominal pain, and high-grade fever. Laboratory tests revealed leukocytosis and increased C-reactive protein. Contrast-enhanced computed tomography revealed bowel wall thickening with a reduced contrast effect within the colon, in addition to ascites. Sigmoidoscopy revealed extensive sloughing of the mucosa. Her symptoms and laboratory findings improved immediately after the initiation of prednisolone therapy. Pre-discharge total colonoscopy revealed mucosal repair in most of the colon. Clinicians should acknowledge that severe acute colitis can occur after COVID-19 vaccination.

一名 74 岁的妇女在接种了第六针冠状病毒病-2019(COVID-19)mRNA 疫苗后,患上了急性重症结肠炎。接种后第二天,她出现了血性腹泻、腹痛和高烧。实验室检查显示白细胞增多,C反应蛋白升高。造影剂增强计算机断层扫描显示肠壁增厚,结肠内造影剂效果减弱,此外还伴有腹水。乙状结肠镜检查发现黏膜广泛脱落。开始使用泼尼松龙治疗后,她的症状和实验室检查结果立即得到改善。出院前的全结肠镜检查显示大部分结肠粘膜已修复。临床医生应该认识到,接种 COVID-19 疫苗后可能会出现严重的急性结肠炎。
{"title":"Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination: A Case Report.","authors":"Akira Nakanishi, Sakuma Takahashi, Tomoki Inaba, Eriko Yasutomi, Hugh Shunsuke Colvin, Koichi Izumikawa, Shigenao Ishikawa, Masaki Wato, Midori Ando, Satoko Nakamura","doi":"10.2169/internalmedicine.4224-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4224-24","url":null,"abstract":"<p><p>A 74-year-old woman developed acute severe colitis after receiving her sixth mRNA vaccine against coronavirus disease-2019 (COVID-19). On the day after vaccination, she experienced bloody diarrhea, abdominal pain, and high-grade fever. Laboratory tests revealed leukocytosis and increased C-reactive protein. Contrast-enhanced computed tomography revealed bowel wall thickening with a reduced contrast effect within the colon, in addition to ascites. Sigmoidoscopy revealed extensive sloughing of the mucosa. Her symptoms and laboratory findings improved immediately after the initiation of prednisolone therapy. Pre-discharge total colonoscopy revealed mucosal repair in most of the colon. Clinicians should acknowledge that severe acute colitis can occur after COVID-19 vaccination.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enlargement of Gastric Hyperplastic Polyps Arising from Helicobacter heilmannii sensu strico-infected Mucosa after the Successful Eradication of Helicobacter pylori and the Long-Term Use of a Proton Pump Inhibitor. 成功根除幽门螺旋杆菌并长期使用质子泵抑制剂后,由幽门螺旋杆菌感染黏膜引起的胃增生性息肉增大。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4230-24
Masayuki Kurimoto, Hajime Honjo, Saki Yoshida, Natsuki Okai, Yasuo Otsuka, Yasuhiro Masuta, Sho Masaki, Ken Kamata, Kosuke Minaga, Osamu Maenishi, Masatoshi Kudo, Tomohiro Watanabe

Helicobacter pylori eradication is effective for the regression of gastric hyperplastic polyps (GHPs). We report a case which demonstrated an enlargement of GHPs after H. pylori eradication. The patient, who received long-term proton-pump inhibitor (PPI) therapy, lived with a dog, a natural host of Helicobacter heilmanii sensu stricto. Gastric colonization with Helicobacter heilmannii s.s. was observed after H. pylori eradication, thus suggesting the involvement of non-H. pylori Helicobacter species (NHPHs) infection for the enlargement of GHPs, in addition to the proliferative effects of PPI use on the gastric epithelium. Screening for NHPHs may be necessary in dog lovers to avoid paradoxical responses to H. pylori eradication.

根除幽门螺杆菌对胃增生性息肉(GHPs)的消退很有效。我们报告了一例幽门螺杆菌根除后胃增生息肉增大的病例。该患者长期接受质子泵抑制剂(PPI)治疗,与一只狗生活在一起,而狗是严格意义上的黑曼氏螺旋杆菌的天然宿主。在根除幽门螺杆菌后,观察到胃中有黑曼尼氏螺旋杆菌定植,这表明除了使用 PPI 对胃上皮细胞有增殖作用外,非幽门螺杆菌螺旋杆菌(NHPHs)感染也是导致 GHPs 增大的原因之一。可能有必要在爱犬人士中筛查非幽门螺杆菌,以避免对根除幽门螺杆菌产生自相矛盾的反应。
{"title":"Enlargement of Gastric Hyperplastic Polyps Arising from Helicobacter heilmannii sensu strico-infected Mucosa after the Successful Eradication of Helicobacter pylori and the Long-Term Use of a Proton Pump Inhibitor.","authors":"Masayuki Kurimoto, Hajime Honjo, Saki Yoshida, Natsuki Okai, Yasuo Otsuka, Yasuhiro Masuta, Sho Masaki, Ken Kamata, Kosuke Minaga, Osamu Maenishi, Masatoshi Kudo, Tomohiro Watanabe","doi":"10.2169/internalmedicine.4230-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4230-24","url":null,"abstract":"<p><p>Helicobacter pylori eradication is effective for the regression of gastric hyperplastic polyps (GHPs). We report a case which demonstrated an enlargement of GHPs after H. pylori eradication. The patient, who received long-term proton-pump inhibitor (PPI) therapy, lived with a dog, a natural host of Helicobacter heilmanii sensu stricto. Gastric colonization with Helicobacter heilmannii s.s. was observed after H. pylori eradication, thus suggesting the involvement of non-H. pylori Helicobacter species (NHPHs) infection for the enlargement of GHPs, in addition to the proliferative effects of PPI use on the gastric epithelium. Screening for NHPHs may be necessary in dog lovers to avoid paradoxical responses to H. pylori eradication.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of duodenal adenocarcinoma with a gastric phenotype demonstrating a rapidly progressive course. 一例具有胃表型的十二指肠腺癌,病程进展迅速。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4004-24
Sho Matsuyama, Akihisa Fukuda, Nobukazu Agatsuma, Masahito Hoki, Takahiro Utsumi, Hiroshi Seno

We herein report a rare case of duodenal adenocarcinoma with a rapidly progressive course. Esophagogastroduodenoscopy revealed Brunner's gland hyperplasia in the bulbs of the duodenum three years prior to this presentation. Two years earlier, gastric foveolar metaplasia had been observed in the bulbs. One year earlier, the lesion had increased slightly in size. At this time, the lesion had markedly increased in size, and the duodenum was circumferentially stenotic due to the mass. Pathologically, he was diagnosed with duodenal adenocarcinoma with a gastric-dominant immunophenotype and he died two months later. Although extremely rare, we should keep in mind that duodenal tumors with a gastric phenotype may sometimes progress rapidly within a short period of time.

我们在此报告一例病程进展迅速的十二指肠腺癌罕见病例。三年前,食管胃十二指肠镜检查发现十二指肠球部有布鲁纳腺增生。两年前,在十二指肠球部发现了胃窝状赘生物。一年前,病变略有增大。此时,病灶明显增大,十二指肠因肿块而呈环形狭窄。病理诊断为十二指肠腺癌,免疫表型以胃为主,两个月后死亡。虽然极为罕见,但我们应该记住,具有胃表型的十二指肠肿瘤有时会在短时间内迅速发展。
{"title":"A case of duodenal adenocarcinoma with a gastric phenotype demonstrating a rapidly progressive course.","authors":"Sho Matsuyama, Akihisa Fukuda, Nobukazu Agatsuma, Masahito Hoki, Takahiro Utsumi, Hiroshi Seno","doi":"10.2169/internalmedicine.4004-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4004-24","url":null,"abstract":"<p><p>We herein report a rare case of duodenal adenocarcinoma with a rapidly progressive course. Esophagogastroduodenoscopy revealed Brunner's gland hyperplasia in the bulbs of the duodenum three years prior to this presentation. Two years earlier, gastric foveolar metaplasia had been observed in the bulbs. One year earlier, the lesion had increased slightly in size. At this time, the lesion had markedly increased in size, and the duodenum was circumferentially stenotic due to the mass. Pathologically, he was diagnosed with duodenal adenocarcinoma with a gastric-dominant immunophenotype and he died two months later. Although extremely rare, we should keep in mind that duodenal tumors with a gastric phenotype may sometimes progress rapidly within a short period of time.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bacteremia and meningitis caused by penicillin-resistant Streptococcus pneumoniae serotype 35B successfully treated with ceftriaxone combined with vancomycin followed by linezolid: A case report. 耐青霉素肺炎链球菌血清型 35B 引起的菌血症和脑膜炎:病例报告,头孢曲松联合万古霉素和利奈唑胺治疗成功。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.3904-24
Mifumi Tomioka, Kiwamu Nakamura, Shaoqing Duan, Kazuaki Matsumoto, Takahiro Shindo, Keisuke Hoshi, Mika Nagao, Fuminari Oshima, Yasuka Hara, Yoshiyuki Namai

We herein report a case of bacterial meningitis and bacteremia in a 3-month-old boy caused by Streptococcus pneumoniae serotype 35B multidrug resistance. Intravenous ampicillin was administered on admission. However, when pneumococcal meningitis was suspected, the antibiotic treatment was changed to ceftriaxone (CTRX) and vancomycin (VCM). However, owing to difficulties in achieving sufficient serum trough levels of VCM, this treatment was again switched to linezolid (LZD). The patient recovered without complications after 16 days of CTRX and LZD treatment. This case suggests that LZD is a viable treatment option for bacterial meningitis.

我们在此报告一例由肺炎链球菌血清型 35B 多药耐药性引起的 3 个月大男婴细菌性脑膜炎和菌血症病例。患者入院时静脉注射了氨苄西林。然而,当怀疑患上肺炎球菌脑膜炎时,抗生素治疗改为头孢曲松(CTRX)和万古霉素(VCM)。然而,由于万古霉素难以达到足够的血清谷值水平,治疗再次改为利奈唑胺(LZD)。经过 16 天的 CTRX 和 LZD 治疗后,患者康复,未出现并发症。该病例表明,LZD 是治疗细菌性脑膜炎的一种可行方案。
{"title":"Bacteremia and meningitis caused by penicillin-resistant Streptococcus pneumoniae serotype 35B successfully treated with ceftriaxone combined with vancomycin followed by linezolid: A case report.","authors":"Mifumi Tomioka, Kiwamu Nakamura, Shaoqing Duan, Kazuaki Matsumoto, Takahiro Shindo, Keisuke Hoshi, Mika Nagao, Fuminari Oshima, Yasuka Hara, Yoshiyuki Namai","doi":"10.2169/internalmedicine.3904-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.3904-24","url":null,"abstract":"<p><p>We herein report a case of bacterial meningitis and bacteremia in a 3-month-old boy caused by Streptococcus pneumoniae serotype 35B multidrug resistance. Intravenous ampicillin was administered on admission. However, when pneumococcal meningitis was suspected, the antibiotic treatment was changed to ceftriaxone (CTRX) and vancomycin (VCM). However, owing to difficulties in achieving sufficient serum trough levels of VCM, this treatment was again switched to linezolid (LZD). The patient recovered without complications after 16 days of CTRX and LZD treatment. This case suggests that LZD is a viable treatment option for bacterial meningitis.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to the Letter. 回信。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4615-24
Ryo Wada, Masaya Shinohara, Hideki Koike, Rine Nakanishi, Tadashi Fujino, Takanori Ikeda
{"title":"Reply to the Letter.","authors":"Ryo Wada, Masaya Shinohara, Hideki Koike, Rine Nakanishi, Tadashi Fujino, Takanori Ikeda","doi":"10.2169/internalmedicine.4615-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4615-24","url":null,"abstract":"","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Treat Persistent Atrial Fibrillation in Patients with Dextrocardia and Situs Inversus. 如何治疗右心室突出和病位倒置患者的持续性心房颤动?
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4378-24
Naoya Kataoka, Teruhiko Imamura
{"title":"How to Treat Persistent Atrial Fibrillation in Patients with Dextrocardia and Situs Inversus.","authors":"Naoya Kataoka, Teruhiko Imamura","doi":"10.2169/internalmedicine.4378-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4378-24","url":null,"abstract":"","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization. 一例肺栓塞术后确诊的抗 OJ 抗体阳性抗异烟酸酶肌病病例
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-08 DOI: 10.2169/internalmedicine.4201-24
Yu Nakanishi, Hirofumi Watanabe, Yoshihiro Tsuyuki, Mako Tsuyuki, Shinji Kakumoto, Masaaki Abe, Kosuke Hamai

Idiopathic inflammatory myopathies, such as dermatomyositis, are implicated as possible risk factors for venous thromboembolism. We herein report the first known case of a 50-year-old woman who presented to our hospital with a fever, chest pain, and elevated creatine kinase levels and was ultimately diagnosed with pulmonary embolism and anti-OJ antibody-positive antisynthetase myopathy. Dermatomyositis may increase the risk of venous thromboembolism, including pulmonary embolism. However, only a few cases of pulmonary embolism developing before the diagnosis of inflammatory myositis have been reported. Idiopathic inflammatory myopathy should be considered as a differential diagnosis when creatine kinase levels are elevated in patients with pulmonary embolism.

特发性炎症性肌病,如皮肌炎,被认为是静脉血栓栓塞症的可能危险因素。我们在此报告了第一例已知病例,一名 50 岁女性因发热、胸痛和肌酸激酶水平升高到我院就诊,最终被诊断为肺栓塞和抗 OJ 抗体阳性的抗肌酸激酶肌病。皮肌炎可能会增加静脉血栓栓塞(包括肺栓塞)的风险。不过,在确诊炎症性肌炎之前出现肺栓塞的病例仅有少数报道。当肺栓塞患者肌酸激酶水平升高时,应将特发性炎症性肌病视为鉴别诊断。
{"title":"A Case of Anti-OJ Antibody-positive Antisynthetase Myopathy Diagnosed after Pulmonary Embolization.","authors":"Yu Nakanishi, Hirofumi Watanabe, Yoshihiro Tsuyuki, Mako Tsuyuki, Shinji Kakumoto, Masaaki Abe, Kosuke Hamai","doi":"10.2169/internalmedicine.4201-24","DOIUrl":"https://doi.org/10.2169/internalmedicine.4201-24","url":null,"abstract":"<p><p>Idiopathic inflammatory myopathies, such as dermatomyositis, are implicated as possible risk factors for venous thromboembolism. We herein report the first known case of a 50-year-old woman who presented to our hospital with a fever, chest pain, and elevated creatine kinase levels and was ultimately diagnosed with pulmonary embolism and anti-OJ antibody-positive antisynthetase myopathy. Dermatomyositis may increase the risk of venous thromboembolism, including pulmonary embolism. However, only a few cases of pulmonary embolism developing before the diagnosis of inflammatory myositis have been reported. Idiopathic inflammatory myopathy should be considered as a differential diagnosis when creatine kinase levels are elevated in patients with pulmonary embolism.</p>","PeriodicalId":13719,"journal":{"name":"Internal Medicine","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142619674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Internal Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1